Jefferies initiated a buy rating on Medanta (Global Health) with a buy rating and a target price of Rs 550. Medanta is a top-notch healthcare provider with strong brand equity, the brokerage said.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!